MEDX:NSD-Horizon Kinetics Medical ETF (USD)

ETF | Others |

Last Closing

USD 28.54

Change

-0.28 (-0.98)%

Market Cap

N/A

Volume

600.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

-0.30 (-0.14%)

USD 34.39B
IBIT iShares Bitcoin Trust

-0.01 (-0.02%)

USD 29.98B
ACWI iShares MSCI ACWI ETF

-0.24 (-0.20%)

USD 19.27B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.01 (+0.02%)

USD 17.71B
CGABL The Carlyle Group Inc. 4.625% ..

-0.09 (-0.46%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-2.15 (-2.56%)

USD 5.55B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 4.32B
USCL iShares Climate Conscious & Tr..

+0.09 (+0.12%)

USD 2.36B
TSLL Direxion Shares ETF Trust - Di..

+0.21 (+1.07%)

USD 2.26B
PABU iShares Paris-Aligned Climate ..

+0.14 (+0.21%)

USD 2.10B

ETFs Containing MEDX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.18% 43% F 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.18% 30% F 47% F
Trailing 12 Months  
Capital Gain 1.53% 30% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.53% 22% F 39% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.83% 50% F 41% F
Dividend Return 0.83% 45% F 37% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 2.05% 96% N/A 99% N/A
Risk Adjusted Return 40.70% 59% D- 71% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector